Page last updated: 2024-11-03

ro 31-8220 and Diabetes Mellitus, Adult-Onset

ro 31-8220 has been researched along with Diabetes Mellitus, Adult-Onset in 2 studies

Ro 31-8220: a protein kinase C inhibitor

Research Excerpts

ExcerptRelevanceReference
"Wortmannin did not inhibit PKC directly in vitro, or the PKC-dependent effects of phorbol esters on glucose transport in intact adipocytes."1.29The phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits insulin-induced activation of phosphatidylcholine hydrolysis and associated protein kinase C translocation in rat adipocytes. ( Avignon, A; Bandyopadhyay, G; Farese, RV; Standaert, ML; Yamada, K, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meijer, L1
Flajolet, M1
Greengard, P1
Standaert, ML1
Avignon, A1
Yamada, K1
Bandyopadhyay, G1
Farese, RV1

Reviews

1 review available for ro 31-8220 and Diabetes Mellitus, Adult-Onset

ArticleYear
Pharmacological inhibitors of glycogen synthase kinase 3.
    Trends in pharmacological sciences, 2004, Volume: 25, Issue:9

    Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinas

2004

Other Studies

1 other study available for ro 31-8220 and Diabetes Mellitus, Adult-Onset

ArticleYear
The phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits insulin-induced activation of phosphatidylcholine hydrolysis and associated protein kinase C translocation in rat adipocytes.
    The Biochemical journal, 1996, Feb-01, Volume: 313 ( Pt 3)

    Topics: Adipose Tissue; Androstadienes; Animals; Biological Transport, Active; Diabetes Mellitus, Type 2; En

1996